AMPK-FOXO1/BCL6-CD36NAFLD

Miao Zhang1, Keting Dong1, Qian Du1

  • 1Medical School, University of Chinese Academy of Sciences, Beijing, 101400, China.

PubMed
概括

化学合成的骨质卡尔 (csOCN) 通过通过AMPK-FOXO1/BCL6通路调节CD36表达来减少非酒精性脂肪性肝病 (NAFLD) 中的肝脂肪积累,这为向治疗提供了潜力.